Kardiologia Polska 2017 nr 07-30

 

STUDIUM PRZYPADKU / CLINICAL VIGNETTE

Silent early migration of a Figulla® septal occluder into the left ventricle

Bezobjawowe wczesne przemieszczenie okludera ASD typu Figulla® do lewej komory

Alejandro Gutiérrez-Barrios1, Juan M. Lacal-Peña2, Jose M. Vignau-Cano3, Anibal Bermudez-García3, Jesús Oneto-Otero2

1Department of Cardiology, Hospital Puerta del Mar, Cádiz, Spain
2Department of Cardiology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain
3Department of Cardiovascular surgery, Hospital Puerta del Mar, Cádiz, Spain

Address for correspondence:
Alejandro Gutiérrez-Barrios, MD, Avenida Ana de Viya 21. 11009, tel: +34 620 688877, e-mail: aleklos@hotmail.com

A 61-year-old woman with a history of obesity and paroxysmal atrial fibrillation was referred to our institution because of progressive dyspnoea. Transthoracic and transoesophageal echocardiography revealed a 19-mm secundum atrial septal defect (ASD) with adequate rims, suitable for percutaneous closure and a left to right shunt with right-sided heart enlargement. The procedure was performed under intracardiac echocardiographic and fluoroscopic guidance. A 21-mm waist diameter Occlutech Figulla ASD occluder (Occlutech GmbH, Jena, Germany) was successfully delivered with good positioning at the final intracardiac echographic and fluoroscopic control. The following day the patient appeared asymptomatic and in a haemodynamically stable condition. Surprisingly, follow-up transthoracic echocardiography revealed embolisation of the device. The ASD occluder was swinging freely in the left ventricle (LV) bulging into the left ventricular outflow tract (LVOT) and the aortic valve during systole. The device was rotating inside the LV, at times being oriented parallel to the flow and avoiding significant LVOT obstruction, but more worryingly, at other times, the device was transversal to the flow (Fig. 1). Although haemodynamically stable, the patient was immediately referred for surgical removal and repair of the ASD. The device was found to be embolised entirely into the LV (Fig. 2). Through the ASD, the device was gently retrieved without injury to the mitral valve and the septal defect was closed with a bovine pericardial patch. The patient had an uneventful recovery and was discharged a week later. Percutaneous ASD closure is an established safe alternative to surgery with rare complications and high primary success rate. Although device embolisation is a well-known complication, LV embolisation is rarely encountered. (Supplementary video files — see journal website)

Conflict of interest: none declared

313230.jpg 

Figure 1. A. Echocardiography parasternal long-axis view, showing the septal occluder device (arrow) located in the left ventricle longitudinally to the outflow tract, swinging and trying to cross the aortic valve; B. Echocardiography parasternal long-axis view. The device has rotated (arrow) and is oriented transversely to the outflow tract and seems to be swayed by the mitral valve.

Barrios_02.tif 

Figure 2. Intraoperative view of surgical occluder device removal (black arrow)

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl